Back to the main directory
EarningsReview / Equity
- In the Flow by BNP Paribas Exane
- Feeling a bit lacklustre by BNP Paribas Exane
- Aster DM Healthcare (ASTERDM IN) by HSBC
- Surgical Science (Buy, TP: SEK218.00) - Turning the page on 2024 – starting with an acquisition by DnB Markets
- A. P. Møller Mærsk (Hold, TP: DKK11700.00) - Potential for USD4bn–8bn EBITDA by DnB Markets
- Electrolux Professional (Hold, TP: SEK78.00) - Ticking along by DnB Markets
- DHT Holdings (Buy, TP: USD14.00) - Attractive VLCC risk/reward by DnB Markets
- Stillfront Group Minor model adjustments by DnB Markets
- Guidance range within consensus, acquisition pipeline notable by BNP Paribas Exane
- Thoughts On CEO Transition And Preliminary Results by BNP Paribas Exane
- Palantir Technologies (PLTR US) by HSBC
- Repairing, rebasing, relaunching by BNP Paribas Exane
- ’25 guide falls short of street; fundamentals expected to improve by BNP Paribas Exane
- January SAAR: In-Line Start Ahead of Tariffs Frenzy by BNP Paribas Exane
- History Doesn’t Repeat Itself, But It Soon Reshores by BNP Paribas Exane
- Tariff fallout: Sector winners and losers by BNP Paribas Exane
- What a protection ‘racket’ by BNP Paribas Exane
- Scatec - Screening better and better by Danske Bank Equity Research
- Q1 FY25 first look by BNP Paribas Exane
- January 2025 P&C renewals: Net profitability maintained by BNP Paribas Exane
- INVEST SECURITIES - CARMAT : Un coup de pouce financier, newsflow dense en 2025 - ACHAT, OC 3,0€ vs 3,3€ by Invest Securities
- INVEST SECURITIES - CARMAT : OSE-127 sera mis à l'honneur à l'édition 2025 de l'ECCO - ACHAT, OC 13,5€ by Invest Securities
- Publicis Groupe SA - Les ratios financiers les plus élevés de l’industrie by MidCap Partners
- Biomérieux - Preview by MidCap Partners
- Maisons du Monde SA - Un T4 en ligne avec nos attentes, bonne nouvelle sur le cash by MidCap Partners
- Stay Nimble - Trump Tariffs 2.0: Assessing Potential Winners and Losers in US HPC & Beverages by BNP Paribas Exane
- Q4 results in-line, Q1 guide a miss by BNP Paribas Exane
- Autoliv (Buy, TP: SEK1210.00) - Trumped by tariffs by DnB Markets
- NTG (Buy, TP: DKK375.00) - by DnB Markets
- Scatec (Buy, TP: NOK90.00) - Few surprises in Q4 by DnB Markets
- Elopak (Hold, TP: NOK45.00) - Soft finish to a strong year by DnB Markets
- Dorian LPG Minor model adjustments by DnB Markets
- Divi’s Laboratories (DIVI IN) by HSBC
- Exxon Mobil (XOM US) by HSBC
- FSLR ’25 Guide & Warranty, GEV / Chevron, PJM Auction Cap, ENPH 1Q25 by BNP Paribas Exane
- Fortune to favour the brave? by BNP Paribas Exane
- Refining & Petchems: Pictures and profits by BNP Paribas Exane
- Bavarian Nordic - Hold (Buy/DKK 360): Undervalued but likely to remain so for a while by Nordea
- Better Than Feared by BNP Paribas Exane
- The Forest and The Trees: (-) View Unchanged Post 2Q Results by BNP Paribas Exane
- FY24 First Take: Q4 in line, FY25 another back end loaded year by BNP Paribas Exane
- Q4-24 First Take by BNP Paribas Exane
- Holmen - Lumber lords hold fast by Danske Bank Equity Research
- Solid end to 2024, FY 25 guidance in line with estimates by BNP Paribas Exane
- Unicaja - Generous dividends compensate for higher provisions by JB Capital Markets
- FY24 results: rental growth suggests upside to earnings guidance by BNP Paribas Exane
- H125 results: modest H1 beat but weaker outlook by BNP Paribas Exane
- Racing Force SpA - Une fin d’année sous DRS by MidCap Partners
- Global Bioenergies - Accord de partenariat dans le SAF by MidCap Partners
- INVEST SECURITIES - BIOPHYTIS : Quand un effet indésirable devient une opportunité - ACHAT vs NEUTRE, OC 0,82€ vs 2,21€ by Invest Securities